Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Temocillin pharmacokinetics in paediatrics
2014-004224-22Phase 4Completed
- Sponsor
- UCLouvain
- Start
- Dec 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of temocillin in bacterial disease and Infection (3 cohorts), sponsored by UCLouvain. Primary endpoints: Temocillin pharmacokinetics (total and free concentrations) and Minimal inhibitory concentrations (MICs) of bacterial strains. Started Dec 2015; status: completed.
02
Drugs
temocillin
03
Conditions
bacterial diseaseInfection
Beyond the preview
Go deeper on 2014-004224-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-004224-22.